Earnings Summary: Bio-Rad Laboratories Q4
Benzinga Insights 8 months ago
Earnings
The earnings results for Bio-Rad Laboratories (NYSE:BIO) for Q4 were made public on Thursday, February 12, 2026 at 04:15 PM.
Here's a comprehensive overview of the announcement.
Earnings
Bio-Rad Laboratories missed estimated earnings by -5.28%, reporting an EPS of $2.51 versus an estimate of $2.65.
Revenue was up $25.70 million from the same period last year.
Historical Earnings Summary
In the previous quarter, the company beat on EPS by $0.18, resulting in a 4.65% drop change in the share price the following day.
Here's a look at Bio-Rad Laboratories's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 2.08 | 1.82 | 1.78 | 2.88 |
| EPS Actual | 2.26 | 2.61 | 2.54 | 2.90 |
| Revenue Estimate | 651.35M | 612.59M | 573.23M | 679.75M |
| Revenue Actual | 653.00M | 651.60M | 585.40M | 667.50M |
To track all earnings releases for Bio-Rad Laboratories visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.